Amgen 2014 Business Review | Amgen Inc.

Amgen 2014 Business Review

Tuesday, 10.28.2014 from 8:00 AM to 12:00 PM EDT

Click here for webcast

Supporting Materials

2014 Business Review – Bradway 1.3 MB

Amgen Research & Development – Harper 2.6 MB

Kyprolis (carfilzomib) for injection and Blinatumomab - Cagnoni 1.3 MB

Commercial Strategy - Hooper 2.5 MB

Biosimilars - Foraker 888.2 KB

Financial Strategy - Meline 1.3 MB

Closing Remarks - Bradway 815.8 KB

Reconciliations 201.2 KB

Live Teleconference Information

Primary # -

Secondary # -

Passcode -

37934439

Replay Teleconference Information

Start Date -

Oct 28, 2014 at 1:30 PM EDT

Primary # -

Secondary # -

Passcode -

3793 4439#

Location

New York, NY
United States